Kerstin M. Bode-Greuel
-
- Neuroscience and Neuropharmacology Research 6
- Finance top 10%
- Capital Investment and Risk Analysis 4
- Cognitive Neuroscience top 10%
- Neural dynamics and brain function 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 3
-
- Innovative Microfluidic and Catalytic Techniques Innovation 2
-
- Biosimilars and Bioanalytical Methods 2
-
- Innovation Policy and R&D 2
- Pharmaceutical Economics and Policy 2
Kerstin M. Bode-Greuel
14 papers receiving 367 citations
Peers
Comparison fields: 5 of 84
- Cellular and Molecular Neuroscience 227
- Finance 67
- Cognitive Neuroscience 106
- Neurology 42
- Developmental Neuroscience 18
Countries citing papers authored by Kerstin M. Bode-Greuel
This map shows the geographic impact of Kerstin M. Bode-Greuel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin M. Bode-Greuel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin M. Bode-Greuel more than expected).
Fields of papers citing papers by Kerstin M. Bode-Greuel
This network shows the impact of papers produced by Kerstin M. Bode-Greuel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin M. Bode-Greuel. The network helps show where Kerstin M. Bode-Greuel may publish in the future.
Co-authorship network
The 10 scholars most cited alongside Kerstin M. Bode-Greuel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 1 | |
| 2 | 2014 | 3 | |
| 3 | 2013 | 3 | |
| 4 | 2009 | 10 | |
| 5 | 2008 | 12 | |
| 6 | 2005 | 20 | |
| 7 | 2003 | 13 | |
| 8 | 2001 | 78 | |
| 9 | 1992 | 23 | |
| 10 | 1991 | 8 | |
| 11 | Effects of 5-hydroxytryptamine1A-receptor agonists on hippocampal damage after transient forebrain ischemia in the Mongolian gerbil. | 1990 | 40 |
| 12 | 1989 | 116 | |
| 13 | 1988 | 17 | |
| 14 | 1987 | 52 |
About Kerstin M. Bode-Greuel
Kerstin M. Bode-Greuel is a scholar working on Finance, Cellular and Molecular Neuroscience and Neurology, having authored 14 papers that have together received 396 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (6 papers), Capital Investment and Risk Analysis (4 papers), Neural dynamics and brain function (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Innovation Policy and R&D (2 papers) and Pharmaceutical Economics and Policy (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (227 citations), Finance (67 citations) and Cognitive Neuroscience (106 citations). Kerstin M. Bode-Greuel has collaborated with scholars based in Germany, United States and Bulgaria. Frequent co-authors include Wolf Singer, Christoph H. Loch, Joachim Klisch, J. Aldenhoff, Joachim M. Greuel, Klaus Nickisch, E. Horváth, J. Traber, Thomas Gläser and T. Els. Their work appears in journals such as Brain Research, Experimental Brain Research and Neuroscience Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.